Regence Logos
Search: 
spacer
Medical Policy

Surgery Section - Cosmetic and Reconstructive Surgery

Topic: Cosmetic and Reconstructive Surgery Date of Origin: 01/1996
Section: Surgery Policy No: 12
Approved Date: 06/09/2009 Effective Date: 08/01/2009
Next Review Date: 08/2010


IMPORTANT REMINDER

This Medical Policy has been developed through consideration of medical necessity, generally accepted standards of medical practice, and review of medical literature and government approval status.

Benefit determinations should be based in all cases on the applicable contract language. To the extent there are any conflicts between these guidelines and the contract language, the contract language will control.

The purpose of medical policy is to provide a guide to coverage. Medical Policy is not intended to dictate to providers how to practice medicine. Providers are expected to exercise their medical judgment in providing the most appropriate care.

DESCRIPTION

Cosmetic surgery is performed to reshape body structures in order to improve appearance.

Reconstructive surgery is primarily performed to improve or correct a functional impairment.  It may also be performed to restore normal appearance in patients affected by congenital anomalies, injury, disease, or therapeutic interventions (surgery, radiation, chemotherapy).

POLICY/CRITERIA

Many member contracts have very specific language regarding covered reconstructive services and excluded cosmetic procedures.  Specific member contract language has precedence over medical policy, and requests for coverage of potentially cosmetic services should be reviewed by applicable member contract language. 

The following policy may be applied when member contract language is not specific:

  1. If the intervention is intended to treat a functional impairment and if no other contract exclusions apply, it may be considered medically necessary.
  2. If the intervention is not intended to treat a functional impairment, the cause of the condition must be determined, for example, accident/injury/trauma, post-treatment, congenital anomaly, disease.  If the cause is included in the definition of reconstructive services in the benefits contract language, then the treatment may be covered.

The following flow chart may be used as a guide to interpreting benefits language.

Is intervention intended to treat a functional impairment?

----Yes--»
Treatment may be medically necessary.  Check for specific medical necessity criteria.*

I
No


 
Determine cause of condition (accident/injury/trauma, post-treatment, congenital anomaly, disease)
I
Does benefit contract language include the cause of the condition in the definition of reconstructive services?
----Yes--»
Service may be covered
I
No

Service is considered cosmetic

*See additional medical necessity criteria for the following procedures:

Blepharoplasty and Brow Ptosis Repair

Chemical Peels

Dermabrasion and Microdermabrasion

Laser Treatment for Port Wine Stain

Mastectomy for Gynecomastia

Orthognathic Surgery

Pectus Excavatum

Reconstructive Breast Surgery/Mastopexy, and Management of Breast Implants

Reduction Mammaplasty

Varicose Vein Treatment

 

Blepharoplasty and Brow Ptosis Repair                  Return to Flow Chart

Description

Blepharoplasty is a surgical procedure performed on the upper and/or lower eyelids to remove or repair excess tissue that obstructs the field of vision. These procedures may also be performed for cosmetic purposes in the absence of visual field obstruction.

Functional visual impairment occurs when excess upper eyelid tissue overhangs the upper eyelid margin and results in significant superior visual field obstruction.  Visual field studies are used to determine the degree of obstruction.  Visual field studies should be measured both with and without elevation of the excess tissue to determine the extent of visual field defect at rest and the amount of improvement that may be obtained from blepharoplasty. 

Policy/Criteria

  1. Blepharoplasty for the following diagnoses may be considered medically necessary for an affected upper or lower lid without meeting visual loss criteria:
    1. Trichiasis
    2. Ectropion
    3. Entropion
  2. In the absence of one of the conditions listed above, unilateral or bilateral upper lid blepharoplasty or levator resection may be considered medically necessary for reconstructive purposes when at least one eye meets all of the following criteria:
    1. Visual field is limited to 20 degrees or less superiorly, or limited to 10 to 15 degrees or less laterally, AND
    2. Frontal or lateral photographs demonstrate visual field limitation consistent with the visual field examination, AND
    3. Any related disease process, such as myasthenia gravis or a thyroid condition is documented as stable.
  3. Brow ptosis repair may be considered medically necessary for reconstructive purposes when at least one eye meets all of the criteria for blepharoplasty above, and photographs demonstrate the eyebrow is below the supraorbital rim.
  4. In order to determine medical necessity the following information will be requested:
    1. Visual fields, including physician interpretation
    2. Documentation of clinically decreased vision
    3. Lateral and full face photographs
  5. Blepharoplasty in anophthalmia may be considered medically necessary when the upper eyelid position interferes with the fit of a prosthesis in the socket.
  6. Blepharoplasty of the lower lids for excessive skin is considered cosmetic.

Chemical Peels (2)                                                         Return to Flow Chart

Description

A chemical peel refers to a controlled removal of varying layers of the epidermis and superficial dermis with the use of a ‘wounding’ agent, such as phenol or trichloroacetic acid (TCA). The most common indication for chemical peeling is as a treatment of photoaged skin, correcting pigmentation abnormalities, solar elastosis, and wrinkles. However, chemical peeling has also been used as a treatment for various stages of acne and multiple actinic keratoses when treatment of individual lesions is not feasible.

An epidermal peel may be used to remove fine, subtle lines, soften the appearance of enlarged pores, improve the skin texture and lighten hyper-pigmentary disorders. Multiple epidermal peels (also referred to as chemical exfoliation) may also be used in patients with active acne.

Dermal peels may be used to treat deep wrinkling, actinic damage, or actinic keratoses. Acne scarring has also been treated with dermal peels.

Policy/Criteria

Epidermal Chemical Peels

  1. Epidermal chemical peels with 50 - 70% alpha hydroxy acids may be considered medically necessary to treat patients with active acne that have failed a trial of topical and/or oral antibiotic acne therapy.
  2. Epidermal chemical peels for the treatment of photoaged skin, wrinkles, or acne scarring are considered cosmetic.

Dermal Chemical Peels

  1. Dermal chemical peels may be considered medically necessary to treat numerous (>10) actinic keratoses or other premalignant skin lesions, when treatment of the individual lesions becomes impractical.
  2. Dermal chemical peels as treatment of end-stage acne scarring are considered cosmetic.

Dermabrasion and Microdermabrasion                       Return to Flow Chart

Description

Dermabrasion uses a rapidly moving brush to remove skin and activate new skin growth.  It is commonly used for the treatment facial scars and wrinkles.

Microdermabrasion uses small microcrystals to abrade the superficial epidermal layer of the skin; suction is then used to remove any skin debris.  Microdermabrasion is often performed by estheticians for facial rejuvenation.

Policy/Criteria

  1. Dermabrasion to treat photoaged skin, wrinkles, or acne scarring is considered cosmetic.
  2. Microdermabrasion for the treatment of any indication is considered cosmetic.

Laser Treatment of Port Wine Stains                         Return to Flow Chart

Description

Port wine stain (PWS) is a capillary malformation that begins as a pale pink flat area (macular lesion) in childhood and grows as the patient ages. Common areas for PWS to appear are on the face over the areas of the first and second trigeminal nerves and the eyes or mouth. It is common to see a PWS overlying an arteriovenous, arterial or venous malformation. The abnormal blood vessels within the PWS become progressively more dilated in size, which results in the lesion becoming dark purple and elevated in some instances. Nodules and hypertrophy may develop in the soft tissue underlying the PWS. Nodules may continue to grow and can bleed easily if traumatized.  PWS persists into adult life and is associated with systemic abnormalities such as glaucoma.

Treatment of a PWS in its macular stage will prevent the development of the hypertrophic component of the lesion. Laser treatment of a PWS diminishes the existing blood vessels making them smaller, fewer in number, and less likely to progress in size.

Policy/Criteria

  1. Laser treatment may be considered medically necessary for port wine stains.
  2. Destruction of cutaneous vascular lesions for removal of telangiectasias (spider veins) is considered cosmetic.

Mastectomy for Gynecomastia                                   Return to Flow Chart

Description

Gynecomastia refers to the benign enlargement of the male breast, either due to increased adipose tissue, fibrous tissue, glandular tissue, or a combination of all three.  In some instances, adolescent gynecomastia may be reported as tender or painful, however, this pain is normally self-limiting or responds to analgesic therapy. Typically no functional impairment is associated with gynecomastia.

Policy/Criteria

Mastectomy as a treatment of gynecomastia is considered cosmetic.

Pectus Excavatum Repair                                          Return to Flow Chart

Description

Pectus excavatum, commonly referred to as "funnel chest," is a chest wall malformation in which the sternum is depressed inward, causing midline narrowing of the thoracic cavity. Although pectus excavatum may be visually prominent, in most cases the loss of volume is not significant and does not interfere with ventilation. Pectus excavatum is occasionally associated with upper or lower airway obstruction; however, when this condition is successfully treated or resolves spontaneously, the pectus deformity may lessen or disappear. Pectus excavatum may also be associated with segmental bronchomalacia, and in some patients, cardiac function may be adversely affected. In many children, the heart is shifted leftward, and in the rare patient, cardiac function may be adversely affected.

Surgical correction of pectus excavatum is not physiologically beneficial for the vast majority of patients; surgery is most often sought due to psychological and cosmetic concerns. However, for some patients with extreme deformity, operative interventions may be indicated for functional reasons.

Policy/Criteria

Surgical repair of pectus excavatum may be considered medically necessary when at least two of the following medical necessity criteria are met:

  1. Documented progression of the deformity with associated symptoms.
  2. Pulmonary function studies indicate components of restrictive airway disease.
  3. Haller Computerized Tomography (CT) scan index greater than 3.25. This Haller CT index is the ratio derived from a chest CT scan by dividing the transverse diameter by the anterior-posterior diameter.
  4. Cardiac evaluation (electrocardiogram [EKG], chest CT, and/or echocardiogram) demonstrates compression-caused mitral valve prolapse, abnormal rhythm, conduction abnormalities, or significant cardiac deformity.

REFERENCES

  1. BlueCross BlueShield Association Medical Policy Reference Manual, Policy No. 10.01.09
  2. BlueCross BlueShield Association Medical Policy Reference Manual, Policy No. 8.01.16
  3. BlueCross BlueShield Association Medical Policy Reference Manual, Policy No. 7.01.40

CROSS REFERENCES

Orthognathic Surgery, Regence Medical Policy Manual, Surgery, Policy No. 137

Reconstructive Breast Surgery/Management of Breast Implants, Regence Medical Policy Manual, Surgery, Policy No. 40

Reduction Mammoplasty, Regence Medical Policy Manual, Surgery, Policy No. 60

Varicose Vein Treatment, Regence Medical Policy Manual, Surgery, Policy No. 104

CODES  NUMBER  DESCRIPTION
CPT

11920

Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; 6.0 sq cm or less

 

11921

Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; 6.1 to 20.0 sq cm

 

11922

Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; each additional 20.0 sq cm, or part thereof

 

11950

Subcutaneous injection of filling material (eg, collagen); 1 cc or less

 

11951

Subcutaneous injection of filling material (eg, collagen); 1.1 to 5.0 cc

 

11952

Subcutaneous injection of filling material (eg, collagen); 5.1 to 10.0 cc

 

11954

Subcutaneous injection of filling material (eg, collagen); over 10.0 cc

 

15775

Punch graft for hair transplant; 1 to 15 punch grafts

 

15776

Punch graft for hair transplant; more than 15 punch grafts

 

15780

Dermabrasion; total face (eg, for acne scarring, fine wrinkling, rhytids, general keratosis)

 

15781

Dermabrasion; segmental, face

 

15782

Dermabrasion; regional, other than face

 

15783

Dermabrasion; superficial, any site (eg, tattoo removal)

 

15786

Abrasion; single lesion (eg, keratosis, scar)

 

15787

Abrasion; each additional four lesions or less

 

15788

Chemical peel, facial; epidermal

 

15789

Chemical peel; facial; dermal

 

15792

Chemical peel; nonfacial; epidermal

 

15793

Chemical peel; nonfacial; dermal

 

15819

Cervicoplasty

 

15820

Blepharoplasty, lower eyelid

 

15821

Blepharoplasty with extensive herniated fat pad

 

15822

Blepharoplasty, upper eyelid

 

15823

Blepharoplasty, upper eyelid; with excessive skin weighting down lid

 

15824

Rhytidectomy; forehead

 

15825

Rhytidectomy; neck with platysmal tightening (platysmal flap, P-flap)

 

15826

Rhytidectomy; glabellar frown lines

 

15828

Rhytidectomy; cheek, chin and neck

 

15829

Rhytidectomy; superficial musculoaponeurotic system (SMAS) flap


15830 Excision, excessive skin and subcutaneous tissue (includes lipectomy); abdomen, infraumbilical panniculectomy
 

15832

Excision, excessive skin and subcutaneous tissue (includes lipectomy); thigh

 

15833

Excision, excessive skin and subcutaneous tissue (includes lipectomy); leg

 

15834

Excision, excessive skin and subcutaneous tissue (includes lipectomy); hip

 

15835

Excision, excessive skin and subcutaneous tissue (includes lipectomy); buttock

 

15836

Excision, excessive skin and subcutaneous tissue (includes lipectomy); arm

 

15837

Excision, excessive skin and subcutaneous tissue (includes lipectomy); forearm or hand

 

15838

Excision, excessive skin and subcutaneous tissue (includes lipectomy); submental fat pad

 

15839

Excision, excessive skin and subcutaneous tissue (includes lipectomy); other area

  15847 Excision, excessive skin and subcutaneous tissue (includes lipectomy); abdomen (e.g., abdominoplasty) (includes umbilical transposition and fascial plication
 

15876

Suction assisted lipectomy; head and neck

 

15877

Suction assisted lipectomy; trunk

 

15878

Suction assisted lipectomy; upper extremity

 

15879

Suction assisted lipectomy; lower extremity

 

17106

Destruction of cutaneous vascular proliferative lesions (e.g., laser technique); less than 10 sq cm

 

17107

Destruction of cutaneous vascular proliferative lesions (e.g., laser technique); 10.0 to 50.0 sq cm

 

17108

Destruction of cutaneous vascular proliferative lesions (e.g., laser technique); over 50 sq cm

 

17360

Chemical exfoliation for acne (eg, acne paste, acid)

 

17380

Electrolysis epilation, each 30 minutes

 

17999

Unlisted procedure, skin, mucous membrane and subcutaneous tissue

 

19300

Mastectomy for gynecomastia

 

19355

Correction of inverted nipples

 

21137

Reduction forehead; contouring only

 

21138

Reduction forehead; contouring and application of contouring material or bone graft (includes obtaining autograft)

 

21139

Reduction forehead; contouring and setback of anterior frontal sinus wall

 

21244

Reconstruction of mandible, extraoral, with transosteal bone plate (eg, mandibular staple bone plate)

 

21245

Reconstruction of mandible, or maxilla, subperiosteal implant; partial

 

21246

Reconstruction of mandible, or maxilla, subperiosteal implant; complete

 

21248

Reconstruction of mandible or maxilla, endosteal implant (eg, blade, cylinder); partial

 

21249

Reconstruction of mandible or maxilla, endosteal implant (eg, blade, cylinder); complete

 

21270

Malar augmentation, prosthetic material

 

21280

Medial canthopexy

 

21282

Lateral canthopexy

 

21295

Reduction of masseter muscle and bone (eg, for treatment of benign masseteric hypertrophy); extraoral approach

 

21296

Reduction of masseter muscle and bone (eg, for treatment of benign masseteric hypertrophy); intraoral approach

 

21740

Reconstructive repair of pectus excavatum or carinatum; open

 

21742

Reconstructive repair of pectus excavatum or carinatum; minimally invasive approach (Nuss procedure), without thoracoscopy

 

21743

Reconstructive repair of pectus excavatum or carinatum; minimally invasive approach (Nuss procedure), with thoracoscopy

 

26590

Repair macrodactylia, each digit

 

30120

Excision or surgical planing of skin of nose for rhinophyma

 

30400

Rhinoplasty, primary; lateral and alar cartilages and/or elevation of nasal tip

 

30410

Rhinoplasty, primary; complete, external parts including bony pyramid, lateral and alar cartilages, and/or elevation of nasal tip

 

30420

Rhinoplasty, primary; including major septal repair

 

30430

Rhinoplasty secondary; minor revision (small amount of nasal tip work)

 

30435

Rhinoplasty secondary; intermediate revision (bony work with osteotomies)

 

30450

Rhinoplasty secondary; major revision (nasal tip work and osteotomies)

 

31830

Revision of tracheostomy scar

 

41510

Suture of tongue to lip for micrognathia (Douglas type procedure)

 

49250

Umbilectomy, omphalectomy, excision of umbilicus

 

49560

Repair initial incisional or ventral hernia, reducible

 

49565

Repair recurrent incisional or ventral hernia, reducible

 

54360

Plastic operation on penis to correct angulation

 

57291

Construction of artificial vagina; without graft

 

57292

Construction of artificial vagina; with graft

 

57295

Revision (including removal) of prosthetic vaginal graft; vaginal approach

 

57296

Revision (including removal) of prosthetic vaginal graft; open abdominal approach

 

67900

Repair or brow ptosis (supraciliary, mid-forehead or coronal approach)

 

67901

Repair of blepharoptosis; frontalis muscle technique with suture or other material (eg, banked fascia)

 

67902

Repair of blepharoptosis; frontalis muscle technique with autologous fascial sling (includes obtaining fascia)

 

67903

Repair of blepharoptosis; (tarso) levator resection or advancement, internal approach

 

67904

Repair of blepharoptosis;  (tarso) levator resection or advancement, external approach

 

67906

Repair of blepharoptosis; superior rectus technique with fascial sling (includes obtaining fascia)

 

67908

Repair of blepharoptosis; conjunctivo-tarso-Muller’s muscle-levator resection (e.g., Fasanella-Servat type)

 

67909

Reconstruction of overcorrection of ptosis

 

67911

Correction of lid retraction

 

67950

Canthoplasty (reconstruction of canthus)

 

69090

Ear piercing

 

69300

Otoplasty, protruding ear, with or without size reduction

Surgery Section Table of Contents Go

Back to Top